Munafa Stock Market Course + Intraday & FNO calls 
Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for NASDAQ stock ALNY Alnylam Pharmaceuticals. Dated: 13 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 320.66 and Closed at: 333.00, which is 3.27% of previous session's close. It moved within a range of 319.00 and 333.56
The session was a Bullish session with an average volume of 967600, which is 27.8% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- There is some positive change in the long term trend, but its too soon to jump onto conclusions.
A Golden cross was found 7 days back on short term averages
Support for tomorrow is 326 and resistance for tomorrow is 340.56
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 323.48, 313.96 resistance for tomorrow's hourly charts is 338.04, 343.08
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 324.8 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 320.66 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 324.92 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 365.33 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 393.8 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 320.66 and 200 DMA is at 393.8, while 50 DMA and 100 DMA are at 324.92 and 365.33 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 320.66 and 20 EMA is at 323.54
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Apr | 333.00 | 320.66 | 323.54 |
| 10 Fri Apr | 322.11 | 319.87 | 322.55 |
| 09 Thu Apr | 321.28 | 319.78 | 322.6 |
| 08 Wed Apr | 327.25 | 319.84 | 322.74 |
| 07 Tue Apr | 319.52 | 319.66 | 322.27 |
| 06 Mon Apr | 330.34 | 319.71 | 322.56 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 324.92 and 50 EMA is at 333.27
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Apr | 333.00 | 324.92 | 333.27 |
| 10 Fri Apr | 322.11 | 325.2 | 333.28 |
| 09 Thu Apr | 321.28 | 325.75 | 333.74 |
| 08 Wed Apr | 327.25 | 326.42 | 334.25 |
| 07 Tue Apr | 319.52 | 327.1 | 334.54 |
| 06 Mon Apr | 330.34 | 327.87 | 335.15 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 365.33 and 100 EMA is at 353.87
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Apr | 333.00 | 365.33 | 353.87 |
| 10 Fri Apr | 322.11 | 366.49 | 354.29 |
| 09 Thu Apr | 321.28 | 367.81 | 354.94 |
| 08 Wed Apr | 327.25 | 369.13 | 355.62 |
| 07 Tue Apr | 319.52 | 370.37 | 356.19 |
| 06 Mon Apr | 330.34 | 371.6 | 356.93 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 393.8 and 200 EMA is at 360.11
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Apr | 333.00 | 393.8 | 360.11 |
| 10 Fri Apr | 322.11 | 393.74 | 360.38 |
| 09 Thu Apr | 321.28 | 393.76 | 360.77 |
| 08 Wed Apr | 327.25 | 393.72 | 361.17 |
| 07 Tue Apr | 319.52 | 393.63 | 361.51 |
| 06 Mon Apr | 330.34 | 393.59 | 361.93 |
Si Bone has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 1.03% more returns!
Alnylam Pharmaceuticals has performed better than Surgery Partners in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Rigel Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 9.24% more returns!
Alnylam Pharmaceuticals has performed better than Mesoblast in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Medpace Holdings has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Medpace Holdings, about 5.03% more returns!
Livanova Plc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Livanova Plc, about 4.22% more returns!
Alnylam Pharmaceuticals has performed better than Ligand Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Arvinas Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Biolife Solutions has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 3.28% more returns!
Capricor Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 7% more returns!
Alnylam Pharmaceuticals has performed better than Collegium Pharmaceutical in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Crispr Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 6.24% more returns!
Cytokinetics Incorporated has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 4.84% more returns!
Alnylam Pharmaceuticals has performed better than Ensign Group in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than National Vision in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Galapagos Nv in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Halozyme Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Healthways Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Healthways Inc, about 3.23% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 324.78 and Alnylam Pharmaceuticals ALNY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
